CIK 0001101026
- Non-accelerated filer
- Smaller reporting company
Zivo Bioscience, Inc.
Sign in to watch- Ticker
- ZIVO
- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- Operating
- EIN
- 870699977
- Phone
- +1 248-452-9866
- Business address
- 21 E. LONG LAKE ROAD, SUITE 100, BLOOMFIELD HILLS, MI, 48304
- Former names
- HEALTH ENHANCEMENT PRODUCTS INC, WESTERN GLORY HOLE INC
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Director bought 197,000 shares at an average $0.10 ($19,510)
- 4 Open-market buy Director bought 20,000 shares at $0.08 ($1,600)
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 93,000 shares at an average $0.07 ($6,920)
- 4 Open-market buy Director bought 50,000 shares at $0.07 ($3,500)
- 4 Open-market buy Director bought 50,000 shares at $0.08 ($4,000)
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 20,000 shares at $0.07 ($1,350)
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Director bought 84,000 shares at an average $0.07 ($5,778)
- 4 Open-market buy Director bought 114,000 shares at an average $0.07 ($7,467)
- 4 Open-market buy 10% owner bought 107,064 shares at $0.08 ($8,565)
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy 10% owner bought 299,400 shares at $0.13 ($39,850)
- 4 Open-market buy Director bought 50,000 shares at $0.08 ($4,245)
- 4 Open-market buy Director bought 39,069 shares at an average $0.09 ($3,406)
- 4 Open-market buy 10% owner bought 125,400 shares at $0.09 ($10,822)
- 4 Open-market buy 10% owner bought 121,000 shares at an average $0.08 ($9,471)
Page 8 of 12 · 239 filings